window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : October 4, 2025

  • News
  • About Us
Contact Us

CDMOs & Manufacturing

  • CDMOs & Manufacturing,Clinical Development,Oncology,Partnerships & Funding,Research & Development

    XenoSTART and Minerva Imaging expand collaboration on radiopharmaceutical drug development

    XenoSTART and Minerva Imaging have expanded their long-standing partnership to [...]

    October 2, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Supply Chain & Logistics

    Mstack launches Chemstack AI as supply chain crisis drives chemical industry change

    Mstack has launched Chemstack AI, a new platform it says [...]

    September 29, 2025
  • Biomanufacturing,CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Development,Drug Development,Pharmaceuticals and therapeutics,Technology and platforms

    ReiThera: Commercial CDMO capabilities key to manage ‘volatile’ biotech market

    ReiThera will begin commercial production in 2026, a milestone the [...]

    September 25, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics,Technology and platforms

    RION partners with Lonza to scale manufacturing of exosome-based therapeutics

    RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived [...]

    September 23, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics,Supply Chain & Logistics,Technology and platforms

    Merck opens climate-neutral €150 million filter manufacturing facility in Ireland

    Merck has inaugurated its first climate-neutral manufacturing facility in Ireland, [...]

    September 23, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    eXmoor Pharma and Siam Bioscience partner to expand cell and gene therapy services in Southeast Asia

    eXmoor Pharma and Siam Bioscience have announced a strategic partnership [...]

    September 23, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Movers & Shakers,Pharmaceuticals and therapeutics

    Chrysalis appoints Adam Bartley as chief operating officer

    Chrysalis, a provider of GMP cleanroom hosting and support services [...]

    September 23, 2025
  • CDMOs & Manufacturing,Genomics and sequencing,Partnerships & Funding,Research & Development,Technology and platforms

    BioIVT opens new lab facility in Woodbury, New York

    BioIVT has expanded its operations with a new office and [...]

    September 20, 2025
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Partnerships & Funding,Pharmaceuticals and therapeutics,RNA Therapeutics,Technology and platforms

    Evonik and Ethris partner on lipid nanoparticle delivery platform

    Evonik and Ethris have agreed a partnership to develop and [...]

    September 18, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Chronic diseases,Drug Development,Partnerships & Funding

    KBI Biopharma and Infinimmune partner on antibody manufacturing for atopic dermatitis programme

    KBI Biopharma has entered a collaboration with Infinimmune to support [...]

    September 17, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • HeliosX strengthens leadership team to drive global growth and brand innovation
    Categories: Digital Health, Global health, Market Access & Commercialization, Movers & Shakers, Patient Centricity, Pharmaceuticals and therapeutics, Technology and platforms
  • SeaBeLife secures €2 million to advance dual-targeted therapies for dry AMD and severe acute hepatitis
    Categories: Biotech, Clinical Development, Clinical Trials, Drug Development, Global health, Partnerships & Funding, Rare Diseases, Research & Development
  • Amorphical reports positive interim results from ongoing Crohn’s disease trial
    Categories: Chronic diseases, Clinical Development, Clinical studies, Clinical Trials, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top